Kenneth Hoberman Tg Therapeutics, Inc. (TGTX) insider trading activity

Kenneth Hoberman is Director of TG THERAPEUTICS, INC.. Currently has a direct ownership of 264,935 shares of TGTX, which is worth approximately $9.08 Million. The most recent transaction as insider was on Jun 19, 2024, when has been sold 22,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K

0% 3M change

9.17% 12M change

Total Value Held $9.08 Million

Kenneth Hoberman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 19 2024	BUY Grant, award, or other acquisition	-	22,250 Added 7.75%	264,935 Common Stock
Sep 28 2023	BUY Grant, award, or other acquisition	-	20,000 Added 7.61%	242,685 Common Stock
Jul 20 2022	BUY Grant, award, or other acquisition	-	43,732 Added 16.41%	222,685 Common Stock
Jun 18 2021	BUY Grant, award, or other acquisition	-	20,000 Added 10.05%	178,953 Common Stock

Also insider at

NVCT

Nuvectis Pharma, Inc. Healthcare

Director